# Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

> **NCT01313572** · PHASE3 · TERMINATED · sponsor: **Forest Laboratories** · enrollment: 197 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Apadenoson SPECT-MPI
- **DRUG:** Adenosine SPECT-MPI

## Key facts

- **NCT ID:** NCT01313572
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2012-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01313572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01313572, "Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT01313572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*